Ulcifat

Each 10 ml suspension contains: Sucralfate … 1000 mg, Simethicone .… 20 mg.

Each tablet contains sucralfate 1000 mg.

Pharmaceutical form: Suspension - tablets.
Therapeutic category: Anti ulcer.

Composition:

Each 10 ml suspension contains: Sucralfate … 1000 mg.

                                                        Simethicone .… 20 mg.

Each tablet contains sucralfate………………………………….1000 mg.

 

Indications:

Ulcifat is indicated in:

- Short-term treatment ( up to 8 weeks ) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 week unless healing has been demonstrated by X-ray or endoscopic examination.

- Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.   

 

Dosage and Administration:

2 teaspoonfuls 4 times a day, 1 hour before each meal and at bedtime and 2 times a day for preventing ulcers.

While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by X-ray or endoscopic examination.

 
 
Home Page | About Us |  Products |  Facilities | Policies | Contact Us | Site Map